Article
Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements
1 Feb 2010
Abstract excerpt
Hepatocellular carcinoma (HCC) is one of most lethal cancers worldwide. Strategic decisions for the advancement of molecular therapies in this neoplasm require a clear understanding of its molecular classification. Studies indicate aberrant activation of signaling pathways involved in cellular proliferation (e.g., epidermal growth factor and RAS/mitogen-activated protein kinase pathways), survival (e.g.,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
